Mark Pruzanski
2011
In 2011, Mark Pruzanski earned a total compensation of $830.7K as Chief Executive Officer and President at Intercept Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $147,420 |
|---|---|
| Option Awards | $319,325 |
| Salary | $364,000 |
| Total | $830,745 |
Pruzanski received $364K in salary, accounting for 44% of the total pay in 2011.
Pruzanski also received $147.4K in non-equity incentive plan and $319.3K in option awards.
Rankings
In 2011, Mark Pruzanski's compensation ranked 6,322nd out of 10,747 executives tracked by ExecPay. In other words, Pruzanski earned more than 41.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,322 out of 10,747 | 41st |
Division Manufacturing | 2,286 out of 3,960 | 42nd |
Major group Chemicals And Allied Products | 524 out of 1,038 | 50th |
Industry group Drugs | 344 out of 786 | 56th |
Industry Pharmaceutical Preparations | 271 out of 571 | 53rd |
Source: SEC filing on April 12, 2013.
Pruzanski's colleagues
We found two more compensation records of executives who worked with Mark Pruzanski at Intercept Pharmaceuticals in 2011.